Maxim Group downgraded Cellular Biomedicine Group (NASDAQ: CBMG) from Buy to Hold.Analyst Jason Kolbert commented:Shares of CBMG have nearly doubled ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE